LightAir is initiating tests on coronavirus with a leading European virus research stitute. The tests will show h how well the Swedish company's IonFlow technology also prevents contact and airborne transmission of COVID19. A scientific study from Karolinska Institutet has previously shown that the technology inactivates influenza viruses immediately and continuously, and prevents airborne transmission. In the coming months, specific tests will be carried out to show how well IonFlow also neutralizes coronaviruses such as SARS-CoV-2, which causes the disease COVID19, and SARS-CoV-1, which causes the disease SARS. LightAirs patented IonFlow technology and its antiviral properties have previously been the subject of an extensive scientific research study, which was led by Professor Lennart Svensson, Linköping University Hospital, and Professor Hans Wigzell of Karolinska Institutet. The study, published in June 2015 in Nature Scientific Reports, concludes that IonFlow technology prevents contact-based and airborne transmission of the viruses examined, which included those causing influenza and winter vomiting disease.